Evidence map›Paper›PMID 42391179›Full record

ArticlePloS one2026

Diabetes among Indigenous Orang Asli adults in Peninsular Malaysia: Prevalence and associated factors from Orang Asli Health Survey 2022.

Hasimah Ismail, Thamil Arasu Saminathan, Hamizatul Akmal Abd Hamid, Wan Kim Sui, Tania Gayle Robert Lourdes, Noor Ani Ahmad

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hasimah IsmailInstitute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
Thamil Arasu SaminathanInstitute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.ORCID https://orcid.org/0000-0002-8342-0777
Hamizatul Akmal Abd HamidInstitute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.ORCID https://orcid.org/0000-0003-0612-3282
Wan Kim SuiInstitute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
Tania Gayle Robert LourdesInstitute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
Noor Ani AhmadInstitute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) is a growing public health problem globally, and in Malaysia. Orang Asli, the Indigenous population in Peninsular Malaysia, often experience a disproportionate burden of diabetes, driven by social disadvantage, lifestyle transitions, and limited access to healthcare. Given that no nationwide diabetes assessment has been conducted among this under-represented group, this study therefore aimed to determine the prevalence of diabetes and its associated factors among Orang Asli adults in Peninsular Malaysia.

methodsThe Orang Asli Health Survey (OAHS) 2022 was a nationwide cross-sectional survey with a complex sampling design conducted among Orang Asli adults living in non-institutional households across nine states of Peninsular Malaysia. A two-stage stratified sampling strategy was used, with locality (urban, fringe, remote) as the primary stratum and tribe (Senoi, Proto-Malay, Negrito) as the secondary stratum. Data were collected using structured interviewer-administered questionnaires and standardised clinical measurements. Diabetes was defined as self-reported physician-diagnosed diabetes or fasting blood glucose ≥7.0 mmol/L. Descriptive statistics, chi-square tests, and multiple logistic regression were performed using SPSS Version 20, accounting for the complex survey design. The adjusted odds ratios (AORs) and 95% confidence intervals (CIs) were reported.

resultsA total of 9,206 Orang Asli adults participated in the diabetes module. The overall prevalence of diabetes was 16.1% (95% CI: 14.3-17.9). Diabetes prevalence was higher among the females (16.8%), those aged ≥60 years (28.1%), urban residents (21.1%), Proto-Malay (18.8%) and Senoi (14.0%) tribes, participants with no formal or incomplete primary education (19.1%), those with monthly household income ≥RM2000 (21.2%), obese individuals (21.1%), respondents with hypertension (24.2%) and those with high total cholesterol (21.7%). In multivariable analysis, diabetes was significantly associated with age 40-59 years (AOR 1.64; 95% CI: 1.35-1.99) and ≥60 years (AOR 2.14; 95% CI: 1.40-3.28), urban (AOR 1.73; 95% CI: 1.07-2.79) and fringe (AOR 1.63; 95% CI: 1.13-2.35) localities, Senoi (AOR 1.70; 95% CI: 1.08-2.68) and Proto-Malay (AOR 2.41; 95% CI: 1.50-3.86) tribes, incomplete primary education (AOR 1.28; 95% CI: 1.02-1.60), household income ≥RM2000 (AOR 1.47; 95% CI: 1.12-1.93), hypertension (AOR 1.42; 95% CI: 1.03-1.95) and hypercholesterolemia (AOR 2.17; 95% CI: 1.70-2.76).

conclusionsDiabetes is common among Orang Asli adults in Peninsular Malaysia. Older age, urban and fringe residence, specific tribal groups, lower education, higher income, hypertension, and hypercholesterolaemia were associated with diabetes. These findings highlight the need for culturally appropriate diabetes prevention, screening, and management strategies tailored to Orang Asli communities, particularly for the elder subgroup and those living in urbanised settings.

Indexed as

Diabetes Mellitus, Type 2AdultAgedCross-Sectional StudiesFemaleHealth SurveysHumansMalaysiaMaleMiddle AgedPrevalenceRisk FactorsYoung Adult

Identifiers

PMID42391179
PMCPMC13327189

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.